Even though drug makers hiked list prices for hundreds of prescription drugs in January, net prices for branded prescription drugs after rebates and discounts decreased by 3.1% last year, according to a new analysis from Drug Channels Institute. Drug Channels CEO Adam Fein reports that brand drug makers discounted drug list prices by an average of 45%, and those discounts increased faster than list prices. Among the drugs with price hikes so far this year, the typical increase was about...